MDxHealth, Inc.: Extraordinary General Shareholders’ Meeting

6/15/2012 10:03:42 AM

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, held its Extraordinary General Meeting of shareholders in Zaventem today. The shareholders approved all agenda items of the Extraordinary General Meeting of shareholders.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• MDxHealth, Inc.

• Diagnostics

• Medical Dev. & Diag. - Events

• Medical Dev. & Diag. - Investor